ATE322261T1 - Verwendung von hydroxyölsäure und ähnlicher verbindungen bei der herstellung von medikamenten - Google Patents
Verwendung von hydroxyölsäure und ähnlicher verbindungen bei der herstellung von medikamentenInfo
- Publication number
- ATE322261T1 ATE322261T1 AT02783094T AT02783094T ATE322261T1 AT E322261 T1 ATE322261 T1 AT E322261T1 AT 02783094 T AT02783094 T AT 02783094T AT 02783094 T AT02783094 T AT 02783094T AT E322261 T1 ATE322261 T1 AT E322261T1
- Authority
- AT
- Austria
- Prior art keywords
- acid
- hydroxyolic
- medications
- production
- similar compounds
- Prior art date
Links
- 229940079593 drug Drugs 0.000 title abstract 3
- 239000003814 drug Substances 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 title abstract 3
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 239000002253 acid Substances 0.000 title 1
- JBSOOFITVPOOSY-KTKRTIGZSA-N 2-hydroxyoleic acid Chemical compound CCCCCCCC\C=C/CCCCCCC(O)C(O)=O JBSOOFITVPOOSY-KTKRTIGZSA-N 0.000 abstract 2
- 108091006027 G proteins Proteins 0.000 abstract 1
- 102000030782 GTP binding Human genes 0.000 abstract 1
- 108091000058 GTP-Binding Proteins 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 208000008589 Obesity Diseases 0.000 abstract 1
- 230000004075 alteration Effects 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Obesity (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200102269A ES2186576B1 (es) | 2001-10-11 | 2001-10-11 | Acido 2-hidroxioleico para utilizar como medicamento. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE322261T1 true ATE322261T1 (de) | 2006-04-15 |
Family
ID=8499164
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02783094T ATE322261T1 (de) | 2001-10-11 | 2002-10-09 | Verwendung von hydroxyölsäure und ähnlicher verbindungen bei der herstellung von medikamenten |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US20050014831A1 (de) |
| EP (1) | EP1435235B1 (de) |
| JP (1) | JP4737931B2 (de) |
| CN (3) | CN101259122B (de) |
| AT (1) | ATE322261T1 (de) |
| BR (1) | BRPI0213165B8 (de) |
| CA (1) | CA2463348C (de) |
| DE (1) | DE60210488T2 (de) |
| ES (2) | ES2186576B1 (de) |
| MX (1) | MXPA04003255A (de) |
| PT (1) | PT1435235E (de) |
| RU (1) | RU2310445C2 (de) |
| WO (1) | WO2003030891A1 (de) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2229935B1 (es) * | 2003-10-10 | 2006-10-01 | Universitat De Les Illes Balears | Utilizacion del acido hidroxioleico y compuestos analagos del mismo como aditivos alimentarios funcionales. |
| JP2009051732A (ja) * | 2005-12-13 | 2009-03-12 | Meiji Seika Kaisha Ltd | Ｐｐａｒリガンド活性を有する組成物 |
| CN101570481B (zh) * | 2008-04-30 | 2012-02-01 | 上海医药工业研究院 | 一种多羟基长链脂肪酸及其分离提取方法和在抑制芳香化酶活性中的应用 |
| ES2342997B1 (es) * | 2008-12-09 | 2011-06-06 | Universitat De Les Illes Balears | Alpha derivados de acidos grasos cis-monoinsaturados para ser usados como medicamento. |
| ES2345241B1 (es) * | 2009-03-16 | 2011-09-08 | Lipopharma Therapeutics | Uso de 2-hidroxiderivados de acidos grasos poliinsaturados como medicamentos. |
| WO2011089265A1 (en) | 2010-01-25 | 2011-07-28 | Bridge Bioresearch Plc | Use of fatty acid compounds for lowering blood glucose levels |
| CN101985420B (zh) * | 2010-01-29 | 2014-04-30 | 苏州润新生物科技有限公司 | 油酸酯及其制备方法和在制备用于治疗高血压及其并发症的药物中的应用 |
| ES2401629B1 (es) * | 2011-10-07 | 2014-03-04 | Universitat De Les Illes Balears | Enantiómeros de 2-hidroxiderivados de ácidos grasos y su uso como medicamentos. |
| WO2013108428A1 (ja) * | 2012-01-19 | 2013-07-25 | 日本水産株式会社 | 食欲抑制剤 |
| WO2013132092A1 (en) | 2012-03-09 | 2013-09-12 | Pensieve International Plc | Use of monounsaturated fatty acid compounds for controlling the body weight of a dog or a cat |
| EP2900270B1 (de) * | 2012-09-26 | 2019-03-06 | Tangent Reprofiling Limited | Kombination von benzo (iso) oxazolepiperidinen mit konjugierter linolsäure |
| GB201217296D0 (en) | 2012-09-27 | 2012-11-14 | Alta Innovations Ltd | Method of treatment and/or prevention |
| US10047036B2 (en) * | 2014-10-21 | 2018-08-14 | Universitat De Les Illes Balears | Method for the synthesis of hydroxy-triglycerides and uses thereof for the prevention and treatment of diseases |
| US10756968B2 (en) | 2015-01-26 | 2020-08-25 | Rapid7, Inc. | Network resource management devices methods and systems |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61297A (ja) * | 1984-06-12 | 1986-01-06 | 日本油脂株式会社 | オレイン酸の製造法 |
| GB8603621D0 (en) | 1986-02-14 | 1986-03-19 | Habib N | Modifying lipid structure of cell membranes |
| JPS6344843A (ja) * | 1986-08-13 | 1988-02-25 | Kao Corp | 油中水中油型乳化油脂組成物 |
| CN1035925C (zh) * | 1988-11-16 | 1997-09-24 | 许正 | 亲细胞非均质分子脂质的制备方法 |
| US5422371A (en) * | 1992-05-27 | 1995-06-06 | Arch Development Corp. | Methods and compositions for inhibiting 5α-reductase activity |
| CN1118218A (zh) * | 1995-03-16 | 1996-03-13 | 姜训书 | 松籽油的制作方法及松籽保健食用油 |
| CN1118228A (zh) * | 1995-03-16 | 1996-03-13 | 姜训书 | 松籽果酱 |
| GB9506837D0 (en) * | 1995-04-03 | 1995-05-24 | Scotia Holdings Plc | Triglycerides |
| ATE235505T1 (de) * | 1995-10-30 | 2003-04-15 | Oleoyl Estrone Developments S | Oleat monoester von estrogenen zur behandlung von fettleibigkeit |
| US5856537A (en) * | 1996-06-26 | 1999-01-05 | The Scripps Research Institute | Inhibitors of oleamide hydrolase |
| DE19727636C1 (de) * | 1997-06-28 | 1998-11-19 | Rwe Dea Ag | Verfahren zur Herstellung von 2-Alkylcarbonsäuren |
| CN1212867A (zh) * | 1997-09-29 | 1999-04-07 | 宋凤亭 | 防治心脑血管疾病的组合物 |
| EP0948963B1 (de) * | 1998-01-21 | 2003-05-07 | Fideline | Pheromone enthaltende Zusammensetzung zur Minderung von Stress, Angst und Streitsucht in Schweinen |
| US6214875B1 (en) * | 1998-04-14 | 2001-04-10 | Zhenhua Yang | Anticancer effects of specific branched-chain fatty acids and related production process |
| GB2389788B (en) * | 2000-12-23 | 2005-07-20 | Univ Creighton | Methods for inducing apoptosis and inhibiting proliferation in cancer cells |
| DE10130491A1 (de) * | 2001-06-25 | 2003-04-17 | Heirler Horst | Verwendung von mittelkettigen Triglyceriden zur Prävention und Therapie von Adipositas |
-
2001
- 2001-10-11 ES ES200102269A patent/ES2186576B1/es not_active Expired - Fee Related
-
2002
- 2002-10-09 CA CA2463348A patent/CA2463348C/en not_active Expired - Lifetime
- 2002-10-09 MX MXPA04003255A patent/MXPA04003255A/es active IP Right Grant
- 2002-10-09 DE DE60210488T patent/DE60210488T2/de not_active Expired - Lifetime
- 2002-10-09 CN CN2008100917941A patent/CN101259122B/zh not_active Expired - Fee Related
- 2002-10-09 WO PCT/ES2002/000475 patent/WO2003030891A1/es active IP Right Grant
- 2002-10-09 PT PT02783094T patent/PT1435235E/pt unknown
- 2002-10-09 AT AT02783094T patent/ATE322261T1/de active
- 2002-10-09 ES ES02783094T patent/ES2261752T3/es not_active Expired - Lifetime
- 2002-10-09 CN CN2008100917937A patent/CN101259121B/zh not_active Expired - Fee Related
- 2002-10-09 BR BRPI0213165A patent/BRPI0213165B8/pt not_active IP Right Cessation
- 2002-10-09 CN CNB028201132A patent/CN100471492C/zh not_active Expired - Lifetime
- 2002-10-09 JP JP2003533923A patent/JP4737931B2/ja not_active Expired - Lifetime
- 2002-10-09 EP EP02783094A patent/EP1435235B1/de not_active Expired - Lifetime
- 2002-10-09 RU RU2004114229/15A patent/RU2310445C2/ru active
- 2002-10-09 US US10/488,726 patent/US20050014831A1/en not_active Abandoned
-
2008
- 2008-04-15 US US12/082,938 patent/US7851507B2/en not_active Expired - Lifetime
-
2010
- 2010-11-04 US US12/939,641 patent/US8778995B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| RU2310445C2 (ru) | 2007-11-20 |
| CN1688302A (zh) | 2005-10-26 |
| JP2005527479A (ja) | 2005-09-15 |
| CN101259121B (zh) | 2011-04-06 |
| MXPA04003255A (es) | 2005-01-25 |
| EP1435235B1 (de) | 2006-04-05 |
| CN101259122A (zh) | 2008-09-10 |
| BRPI0213165B8 (pt) | 2021-05-25 |
| US7851507B2 (en) | 2010-12-14 |
| US20050014831A1 (en) | 2005-01-20 |
| EP1435235A1 (de) | 2004-07-07 |
| CN101259121A (zh) | 2008-09-10 |
| RU2004114229A (ru) | 2005-04-20 |
| US20090082446A1 (en) | 2009-03-26 |
| CN101259122B (zh) | 2011-04-06 |
| PT1435235E (pt) | 2006-08-31 |
| ES2186576B1 (es) | 2004-09-16 |
| CA2463348C (en) | 2011-04-05 |
| CN100471492C (zh) | 2009-03-25 |
| ES2186576A1 (es) | 2003-05-01 |
| DE60210488D1 (de) | 2006-05-18 |
| US20110136906A1 (en) | 2011-06-09 |
| ES2261752T3 (es) | 2006-11-16 |
| BR0213165A (pt) | 2004-09-14 |
| WO2003030891A1 (es) | 2003-04-17 |
| DE60210488T2 (de) | 2006-12-14 |
| JP4737931B2 (ja) | 2011-08-03 |
| BRPI0213165B1 (pt) | 2018-01-23 |
| US8778995B2 (en) | 2014-07-15 |
| CA2463348A1 (en) | 2003-04-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE322261T1 (de) | Verwendung von hydroxyölsäure und ähnlicher verbindungen bei der herstellung von medikamenten | |
| HUP0202636A2 (hu) | Alkilén-diamin-csoporttal helyettesített heterogyűrűs vegyületek és ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| DE502005010170D1 (de) | Neue langwirksame beta-2-agonisten, und deren verwendung als arzneimittel | |
| ECSP055615A (es) | Nuevos compuestos de amida de ácido carboxílico con efecto antagónico de la hcm, medicamentos que contienen estos compuestos y procedimientos para su preparación | |
| CA2469813A1 (en) | Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5 | |
| ATE469161T1 (de) | Pyrazolderivat, dieses enthaltende medizinische zusammensetzung, medizinische verwendung davon, und zwischenprodukt für dessen herstellung | |
| DE602006019880D1 (de) | Verwendung von thienopyridonderivaten als ampk-aktivatoren und pharmazeutische zusammensetzungen, die diese enthalten | |
| CY1110952T1 (el) | Παραγωγα κινουκλιδινης και η χρηση αυτων ως μουσκαρινικοι ανταγωνιστες υποδοχεων μ3 | |
| CY1114582T1 (el) | Παραγωγα αλκυνυλιου ως ρυθμιστες μεταβολοτροπων υποδοχεων γλουταμινικου οξεος | |
| UY28050A1 (es) | Nuevos compuestos de alquino con efecto antagonico de la hcm y medicamentos que contienen estos compuestos. | |
| RS20050330A (en) | Novel amide compounds with mch antagonistic efe and medicaments comprising said compounds | |
| BR0210167A (pt) | Composto, composição farmacêutica, métodos para modular um receptor ativado com proliferador de peroxissoma, para tratar ou prevenir uma doença ou condição e para abaixar a glicose no sangue, e, uso de um composto | |
| DE69033469T2 (de) | Imidazoalkensäure | |
| EP2062898A3 (de) | Spirocyclische Cyclohexan-Derivate | |
| DE602004001857D1 (de) | Thienopyrimidindione und deren verwendung bei der modulierung von autoimmunerkrankungen | |
| ATE422887T1 (de) | Kondensierte heterozyklische verbindungen | |
| DE60330407D1 (de) | Synthese von Epothilonen, Zwischenprodukte davon, Analoga und ihre Verwendung | |
| ATE529415T1 (de) | Nitrosubstituierte phenylpiperazinverbindungen, deren herstellung und deren verwendung in medikamenten | |
| NO20073830L (no) | Medikamenter for behandling eller forebygging av fibrotiske sykdommer | |
| ATE524478T1 (de) | Substituierte spiro-verbindungen und deren verwendung zur herstellung von arzneimitteln gegen schmerz | |
| SE0302116D0 (sv) | Novel compounds | |
| AU2003274686A1 (en) | Inhibitors of the gpib -vwf interaction, their preparation and use | |
| PE20040749A1 (es) | Piperidinas espirosustituidas como antagonistas selectivos del receptor de la hormona concentradora de melanina | |
| EP2535329A3 (de) | Spiropiperidinderivate | |
| ATE486055T1 (de) | Neue verbindungen, ihre herstellung und verwendung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1435235 Country of ref document: EP |